Modulation of Reoviral Cytolysis (II): Cellular Stemness
Viruses · 2023
DOI: 10.3390/v15071473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Tarryn Bourhill und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada. Hauptthemen laut MEDLINE: Reoviridae, Neoplasms, Orthoreovirus, Oncolytic Viruses. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Breast Cancer Foundation (RNJ), Canadian Institutes of Health Research.
Abstract (Originalsprache)
Oncolytic viruses (OVs) are an emerging cancer therapeutic that are intended to act by selectively targeting and lysing cancerous cells and by stimulating anti-tumour immune responses, while leaving normal cells mainly unaffected. Reovirus is a well-studied OV that is undergoing advanced clinical trials and has received FDA approval in selected circumstances. However, the mechanisms governing reoviral selectivity are not well characterised despite many years of effort, including those in our accompanying paper where we characterize pathways that do not consistently modulate reoviral cytolysis. We have earlier shown that reovirus is capable of infecting and lysing both certain types of cancer cells and also cancer stem cells, and here we demonstrate its ability to also infect and kill healthy pluripotent stem cells (PSCs). This led us to hypothesize that pathways responsible for stemness may constitute a novel route for the modulation of reoviral tropism. We find that reovirus is capable of killing both murine and human embryonic and induced pluripotent stem cells. Differentiation of PSCs alters the cells’ reoviral-permissive state to a resistant one. In a breast cancer cell line that was resistant to reoviral oncolysis, induction of pluripotency programming rendered the cells permissive to cytolysis. Bioinformatic analysis indicates that expression of the Yamanaka pluripotency factors may be associated with regulating reoviral selectivity. Mechanistic insights from these studies will be useful for the advancement of reoviral oncolytic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
ORCID-Profile: Derrick Rancourt, Randal N Johnston
Förderung
- CIHR
- Canadian Breast Cancer Foundation (RNJ)
- Canadian Institutes of Health Research
Zitieren
APA
Bourhill, T., Rohani, L., Kumar, M., Bose, P., Rancourt, D., & Johnston, R. N. (2023). Modulation of Reoviral Cytolysis (II): Cellular Stemness. Viruses. https://doi.org/10.3390/v15071473
Vancouver
Bourhill T, Rohani L, Kumar M, Bose P, Rancourt D, Johnston RN. Modulation of Reoviral Cytolysis (II): Cellular Stemness. Viruses. 2023. doi:10.3390/v15071473
BibTeX
@article{Bourhill2023,
author = {Bourhill, Tarryn and Rohani, Leili and Kumar, Mehul and Bose, Pinaki and Rancourt, Derrick and Johnston, Randal N},
title = {Modulation of Reoviral Cytolysis (II): Cellular Stemness},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15071473}
}
EUVIMED